4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors

M Abdoli, S Giovannuzzi, CT Supuran… - Journal of Enzyme …, 2022 - Taylor & Francis
The treatment of chronic neuropathic pain remains one of the most challenging of all
neurological diseases and very much an art. There exists no consensus for the optimal …
被引用次数：16 相关文章

4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors

M Abdoli, S Giovannuzzi, CT Supuran… - Journal of Enzyme …, 2022 - search.proquest.com
The treatment of chronic neuropathic pain remains one of the most challenging of all
neurological diseases and very much an art. There exists no consensus for the optimal …

4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors

M Abdoli, S Giovannuzzi, CT Supuran… - JOURNAL OF ENZYME …, 2022 - flore.unifi.it
The treatment of chronic neuropathic pain remains one of the most challenging of all
neurological diseases and very much an art. There exists no consensus for the optimal …

4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors

M Abdoli, S Giovannuzzi… - Journal of enzyme …, 2022 - pubmed.ncbi.nlm.nih.gov
The treatment of chronic neuropathic pain remains one of the most challenging of all
neurological diseases and very much an art. There exists no consensus for the optimal …
[HTML] nih.gov

[HTML][HTML] 4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors

M Abdoli, S Giovannuzzi, CT Supuran… - Journal of Enzyme …, 2022 - ncbi.nlm.nih.gov
The treatment of chronic neuropathic pain remains one of the most challenging of all
neurological diseases and very much an art. There exists no consensus for the optimal …

4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors.

M Abdoli, S Giovannuzzi, CT Supuran… - Journal of Enzyme …, 2022 - europepmc.org
The treatment of chronic neuropathic pain remains one of the most challenging of all
neurological diseases and very much an art. There exists no consensus for the optimal …